Bleomycin-induced pulmonary toxicity and treatment with infliximab: A case report

被引：13
|
作者：
Ge, Victor [1 ]
Banakh, Iouri [2 ]
Tiruvoipati, Ravindranath [1 ,3 ]
Haji, Kavi [1 ,3 ]
机构：
[1] Frankston Hosp, Dept Intens Care Med, Frankston, Vic, Australia
[2] Frankston Hosp, Dept Pharm, Frankston, Vic, Australia
[3] Monash Univ, Sch Publ Hlth, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia
来源：
CLINICAL CASE REPORTS | 2018年 / 6卷 / 10期
关键词：
bleomycin; infliximab; intensive care; pulmonary toxicity; respiratory failure; treatment outcome;
D O I：
10.1002/ccr3.1790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical Message Given the current understanding of bleomycin-induced pneumonitis (BIP), the use of tumor necrosis factor alpha (TNF-alpha) inhibitors such as infliximab for late-stage disease appears to be of limited benefit. Further research regarding prevention and management of advanced BIP is required.
引用
收藏
页码：2011 / 2014
页数：4
相关论文
共 50 条
  • [31] Treatment with α-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis
    Kimura, T
    Ishii, Y
    Morishima, Y
    Shibuya, A
    Shibuya, K
    Taniguchi, M
    Mochizuki, M
    Hegab, AE
    Sakamoto, T
    Nomura, A
    Sekizawa, K
    JOURNAL OF IMMUNOLOGY, 2004, 172 (09): : 5782 - 5789
  • [32] Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats
    Recep Akgedik
    Şükran Akgedik
    Harun Karamanlı
    Sema Uysal
    Bülent Bozkurt
    Duygu Ozol
    Ferah Armutcu
    Zeki Yıldırım
    Inflammation, 2012, 35 : 1732 - 1741
  • [33] Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis
    Yoshiro Kai
    Hiroyuki Yoneyama
    Jun Koyama
    Kaoru Hamada
    Hiroshi Kimura
    Kouji Matsushima
    Medical Molecular Morphology, 2007, 40 : 128 - 140
  • [34] BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN BABOONS
    MCCULLOUGH, B
    COLLINS, JF
    JOHANSON, WG
    CLINICAL RESEARCH, 1977, 25 (01): : A38 - A38
  • [35] Case of bleomycin-induced scleroderma
    Inaoki, Makoto
    Kawabata, Chiho
    Nishijima, Chihiro
    Yoshio, Nobuyuki
    Kita, Toshiyuki
    JOURNAL OF DERMATOLOGY, 2012, 39 (05): : 482 - 484
  • [36] Amelioration of bleomycin-induced pulmonary toxicity in interferon-γ knockout mice.
    Chen, ES
    Greenlee, BM
    Wills-Karp, M
    Moller, DR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A928 - A928
  • [37] ANGIOTENSIN-CONVERTING ENZYME - AN INDICATOR OF BLEOMYCIN-INDUCED PULMONARY TOXICITY IN HUMANS
    SORENSEN, PG
    ROMER, FK
    CORTES, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (11): : 1405 - 1408
  • [38] Pirfenidone as salvage treatment for refractory bleomycin-induced lung injury: a case report of seminoma
    Sakamoto, Koji
    Ito, Satoru
    Hashimoto, Naozumi
    Hasegawa, Yoshinori
    BMC CANCER, 2017, 17
  • [39] Involvement of Kruppel-like factor 9 in bleomycin-induced pulmonary toxicity
    Gu, Yue
    Wu, Yan-Bing
    Wang, Li-Hui
    Yin, Jia-Ning
    MOLECULAR MEDICINE REPORTS, 2015, 12 (04) : 5262 - 5266
  • [40] Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease
    Garipidou, V
    Vakalopoulou, S
    Zafiriadou, E
    Tziomalos, K
    Perifanis, V
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 514 - 515
12345